Skip to main content
. 2012 Mar 28;7(3):e34287. doi: 10.1371/journal.pone.0034287

Table 1. Baseline characteristics and unadjusted associations with incident CHD events (n = 2193; number of CHD events = 351).

Variable Mean ± SD / n (%) HR (95% CI) p
Age 73.50±2.85 1.03 (1.00, 1.07) 0.09
Age (categories) 0.03*
70–71 672 (30.6)
72–75 934 (42.6) 0.99 (0.77, 1.27)
76–78 464 (21.2) 1.05 (0.78, 1.41)
79 123 (5.6) 1.59 (1.04, 2.43)
Gender
Men 981 (44.7)
Women 1212 (55.3) 0.52 (0.42, 0.65) <0.001
Race
White 1293 (59.0)
Black 900 (41.0) 0.96 (0.78, 1.19) 0.73
Site
Memphis 1125 (51.3)
Pittsburgh 1068 (48.7) 0.99 (0.79, 1.22) 0.89
Education 0.29*
<high school 532 (24.3)
High school graduate 734 (33.6) 0.81 (0.61, 1.07)
Postsecondary 922 (42.1) 0.87 (0.67, 1.13)
Smoking status 0.03*
Never 1016 (46.3)
Former 956 (43.6) 1.41 (1.13, 1.77)
Current 221 (10.1) 1.49 (1.04, 2.12)
Alcohol, drinks/wk 0.41*
<1 1535 (70.3)
1–7 482 (22.1) 0.88 (0.68, 1.14)
>7 166 (7.6) 1.17 (0.81, 1.70)
Physical activity, kcal/wk 0.20*
<500 1148 (52.3)
500–1500 598 (27.3) 0.96 (0.74, 1.23)
≥1500 447 (20.4) 1.18 (0.91, 1.54)
Hypertension 1258 (57.4) 1.28 (1.03, 1.59) 0.02
Diabetes mellitus 292 (13.3) 1.63 (1.24, 2.13) <0.001
Body mass index, kg/m2 27.41±4.91 1.02 (1.00, 1.04) 0.10
Abdominal circumference 99.43±13.54 1.01 (1.00, 1.02) 0.02
Systolic blood pressure, per 10 mmHg 135.72±20.63 1.09 (1.04, 1.15) <0.001
Diastolic blood pressure, per 10 mmHg 71.59±11.66 1.12 (1.02, 1.22) 0.01
Total cholesterol, per 10 mg/dl 204.83±37.93 0.99 (0.96, 1.01) 0.31
HDL-cholesterol, per 10 mg/dl 55.46±17.12 0.87 (0.81, 0.93) <0.001
Total/HDL-cholesterol 3.98±1.22 1.15 (1.06, 1.25) <0.001
LDL-cholesterol, per 10 mg/dl 122.87±34.44 1.01 (0.98, 1.04) 0.50
Triglycerides, mg/dl 116 (87–160) 1.11 (0.89, 1.39) 0.36
Glucose, per 10 mg/dl 102.46±31.88 1.05 (1.03, 1.08) <0.001
Framingham risk score, % <0.001
<5% 468 (21.3)
5–9.99% 557 (25.4) 1.35 (0.92, 1.99)
10–19.99% 543 (24.8) 2.12 (1.47, 3.04)
≥20% 625 (28.5) 3.06 (2.17, 4.31)
Creatinine, mg/dl 1 (0.9–1.1) 1.96 (1.33, 2.87) 0.001
GFR, ml/min/1.73 m2 # 61.15±15.05 1.00 (0.99, 1.01) 0.87
GFR (categories)** 0.63
≥80 525 (23.9) 1.00
70–79.99 536 (24.5) 1.11 (0.83,1.49)
60–69.99 555 (25.3) 0.87 (0.64,1.18)
<60 576 (26.3) 1.00 (0.75,1.35)
Medication use
Lipid-lowering 229 (10.4) 1.04 (0.75, 1.46) 0.79
Ace inhibitors 273 (12.4) 1.14 (0.84, 1.54) 0.39
Hormone replacement therapy 48 (2.2) 0.82 (0.37, 1.85) 0.64
Aspirin 412 (18.8) 1.31 (1.02, 1.69) 0.03

Abbreviations: SD: standard deviation; HR: hazard ratio; CI: confidence interval; HDL: high-density lipoprotein; LDL: low-density lipoprotein; GFR: glomerular filtration rate.

*p for trend.

Physical activity was assessed by questionnaire about all types of walking and exercise performed in the prior week [14].

Defined by self-report of hypertension and use of anti-hypertensive medications, or measured SBP≥140 and/or DBP≥90 mmHg.

Expressed as median (25%–75%), because of skewed distribution. The effect of the logarithm of the covariates on the CHD is measured.

Classes of CHD risk at 10 years, according to Framingham functions [2].

#

Glomerular filtration rate (GFR) was estimated using the MDRD equation: GFR = 175 * Creatinine−1.154 * Age−0.203 * (1.212*Iblack+Iwhite)* (0.742*Ifemale+Imen) [32].

**Quartiles were used instead of clinical cut-offs to avoid categories with few participants. In particular, categories of GFR<15 and within 15–29.99 were collapsed with the category 30–59.99 (only 0.2% in the class of GFR<15 and 0.5% in the class of GFR within 15–29.99) and a ≥80 category was replaced to the usual ≥90 (only 7% for GFR≥90).